Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis.
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Dermatomyositis; Polymyositis
- Focus Proof of concept; Therapeutic Use
- 26 Oct 2016 Status changed from active, no longer recruiting to completed.
- 05 Aug 2016 Planned End Date changed from 1 May 2016 to 1 Sep 2016.
- 08 Jan 2016 Planned End Date changed from 1 Jul 2016 to 1 May 2016 as reported by ClinicalTrials.gov record